Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for PONV in Gastric Sleeve Surgery
NCT05772676Phase 4Unknown
- Sponsor
- Hospital General Tláhuac
- Start
- Dec 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aprepitant in postoperative nausea and vomiting (PONV), sponsored by Hospital General Tláhuac. Status: unknown.
02
Drugs
aprepitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05772676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05772676.